AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
BPMC(Quitar la ciudad)
Blueprint Medicines·NASDAQ
--
--(--)
Blueprint Medicines (BPMC) Revenue Breakdown
Blueprint Medicines (BPMC) Revenue Breakdown: Q1 2025 Business & Regional Performance
Blueprint Medicines (BPMC) reported total revenue of 149.41M USD in Q1 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 86.64% of total revenue. Explore Blueprint Medicines's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Blueprint Medicines (BPMC) reported total revenue of 149.41M USD in Q1 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 86.64% of total revenue. Explore Blueprint Medicines's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
No Data
